🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

REACH PI Brad was commissioned by the American Museum of Natural History American Museum of Natural History to write on "Can HIV be Cured?". The essay -found here bradjoneslab.org/news, will soon appear in a series on Viruses, Vaccines, and Pandemic Science amnh.org/explore/viruse… Weill Cornell Infectious Diseases Division Immunology & Microbial Pathogenesis (IMP) Program

Stellar annual meeting! Filled with scientific exchange, reflection on our progress & strategizing for the years ahead. Special thanks to our SAB for their insights & to all who participated! Ya-Chi Ho Nussenzweig_LAB Paul Bieniasz Frauke Muecksch The Nixon Lab Ndhlovu Lab #HIVcure

REACH is NYC's first #HIVCure-focused consortium, but we enter into a rich and storied landscape of advocacy, prevention, and vaccine research. What an honor to engage with the community - alongside leaders in these areas - to introduce ourselves and our program!

Team REACH at the 2022 NYC AIDS Walk! We met our fundraising goal in support of GMHC the world's first AIDS service organization and helped raise awareness of the ongoing need #AIDSWalkNY Sallie Permar MD PhD Nussenzweig_LAB Weill Cornell Infectious Diseases Division

Inflammation negatively impacts the health of people with HIV and persists despite ARV therapy. This study by Adam R. Ward and the Brad Jones Lab suggests that ongoing adaptive immune responses are not major drivers of this. #hivcure Weill Cornell Infectious Diseases Division journals.lww.com/aidsonline/Abs…

In this invited Opinion piece we propose how discoveries from other genome-integrating viruses may inform HIV persistence. Noemi Linden #hivcure Weill Cornell Infectious Diseases Division Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses cell.com/trends/immunol…

COVID-19 vaccine exposes HIV hidden in immune cells of people with HIV, pointing to potential new tools in the development of HIV treatment for a cure, according to new findings from a team led by Dr. Brad Jones of Weill Cornell Infectious Diseases Division and Weill Department of Medicine. bit.ly/3prHfb0

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells disq.us/t/4a1xt6f - The net effect is a boost to some HIV-specific immune responses and reductions in the residual HIV RNA that persists in people living with HIV.

#hivcure #nyc #immunology #virology

Proud to be a site for the ACTG Network A5418:Study of Tecovirimat for Human Monkeypox Virus (STOMP). See link below for details. If you have a patient in New York City who needs treatment for #monkeypox see below for information or refer to Weill Cornell Infectious Diseases Division.

Innovating to extend viral assays to diverse HIV subtypes is a core goal of REACH. We were thrilled to these approaches to the challenge of quantifying the remarkably diverse viral reservoirs of this landmark study. Kudos to Dennis C. Copertino Jr Adam R. Ward Natalie Kinloch #hivcure

Day 2 of @IDWeek2022 featured talks by marinacaskey & Dr Ellsworth + posters by Dr. Malderelli, Alexander Drelick, @MSatlin from Weill Cornell Infectious Diseases Division. Weill Department of Medicine

"Communication is key" says Adam Castillejo, the second person ever cured of #HIV Londonpatient_ HOPE here with AVAC Jessica Salzwedel in NYC Because WE ALL NEED an #hivCure for ALL! REACHforthecure Adam R. Ward @talia_mota Flavia NM Moses Supercharger

REACH PI Brad delivered a plenary at @gesida22, where he is also learning about the cutting-edge HIV persistence/cure research being performed in Spain. Keep an eye out for these to be featured on upcoming REACH seminars.

REACH is thrilled to co-sponsor this event in Sept 7th. Join us to hear the latent advances from our distinguished guest speakers, as well as from NYC-local rising stars. Scientists and community members are all welcome.

Back in person for CROI 2023, with two popular poster presentations by Adam R. Ward and @talia_mota, and an outstanding presentation by Noemi Linden! REACHforthecure #HIVcure Immunology & Microbial Pathogenesis (IMP) Program

Our Year 2 Scientific Advisory Board / Annual Meeting was a time to reflect on our accomplishments thus far and to strategize for the road ahead. The science is exciting and the future is bright as we continue to strive for an #hivcure, along with our community and NIH partners.

Join Dr. Marina Caskey of Rockefeller University and members of the REACH CAB as they review the current state of HIV cure research on November 15th, 2023 from 11AM-12:30PM EST. Register today to ask questions and learn more about HIV Cure: tinyurl.com/2vyu2w7m